Key points are not available for this paper at this time.
Despite advances in antifungal therapy, the mortality associated with invasive candidiasis remains as high as 40%. This review summarizes recent trends and current strategies, including early treatment and the emergence of resistance against triazoles and echinocandins.
Kullberg et al. (Thu,) studied this question.